SHANTON

SHANTON is a biotech company, founded in 2016. It has raised $31.2M across 1 round, most recently a $31.2M Series A in December 2020.

Developing novel treatments for gout, hyperuricemia, and pruritus

Employees
1–10
Founded
2016
Total Funding
$31.2M
Last Round
$31.2M Series ADec 2020
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Shanton Pharma is a clinical-stage biotech company founded in 2016, focused on the unmet needs associated with gout, hyperuricemia, and pruritus. The company's mission is to develop novel treatments that address global clinical gaps in these inflammatory and metabolic disease areas, with an ultimate goal of completely eliminating gout. Shanton's pipeline includes SAP-001, which has received FDA Fast Track Designation for refractory gout and has completed an End-of-Phase 2 meeting with the US FDA. The company brings together experienced management with relevant drug development track records and is backed by a group of institutional investors focused on biotech.

Summary

It lists 1–10 employees. It has raised $31.2M in total across 1 round, most recently a $31.2M Series A round in Dec 2020. Investors include BioTrack Capital, Cenova Capital and Lapam Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ADec 2020
$31.2M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SHANTON on Indexed.vc
<a href="https://indexed.vc/companies/shanton"><img src="https://indexed.vc/api/badge/company/shanton" alt="SHANTON on Indexed.vc" width="260" height="76" /></a>